Case Study: Developing Health Systems Resources

Middle East Program in Health Economics and Health Technology Assessment, Bristol-Myers Squibb

Objectives

A 3-module program on Health Economics and Outcomes Research (HEOR) was developed by the University of Washington Department of Pharmacy,  with the support of a grant from  Bristol-Myers Squibb's Middle East/Africa division. The program is designed to  educate decision makers from various countries in the Middle East on the foundational principles of Health Economics and Outcomes Research, in order to critically conduct health economic evaluations of pharmaceuticals and assess health technologies through a Health Technology Assessment. The program allows participants to gain an understanding of decision modeling, patient-reported outcomes, micro-simulation and assessment of uncertainty and principles and practice of Health Technology Assessment (HTA).

Lessons Learned?

Based on experience, the program coordinators decided that the program could be enhanced by providing a pre-assessment of the attendees knowledge to understand their level of expertise and pre-work material to not only set the stage but also begin engaging attendees from the start of the program. These lessons will be applied to future programs.

Results to Date?

Qualitative: Participants were given a strong foundation of HEOR knowledge in a robust framework. Their understanding of the material was reinforced by their engagement in the course.  Participants expressed how the knowledge gained from the program will impact their daily practice and clarified the challenges in decision making by adopting new methods and the role of a health economics department.

Quantitative:  More than 25 representatives from 3 gulf countries (United Arab Emirates, Kuwait and Bahrain) have received training.